Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies
Dear CCBIO members, CCBIO associates, and researchers focusing on biomarker detection through use of patient material and advanced bioinformatics tools. We have the pleasure of inviting you to: Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies Symposium, June 18th-19th 2017 at Solstrand Hotel.
We have brought together speakers with an in-depth knowledge and experience within essential areas of biomarker identification, sharing how they work with clinical samples and bioinformatics in the search for specific biomarkers for a disease or treatment response.
There will also be ample time for interaction between the participants during this meeting. The symposium is open for all, so please feel free to circulate this invitation.
Participants, particularly PhD and MSc students, are encouraged to bring a poster on their work. No abstract required.
SUNDAY 18. June
|13.30‐14.15||Arrival and registration|
|14.30‐15.15||The role of bioinformatics and clinical trials in the|
discovery of biomarkers
|Working with complex data|
|15.40-16.05||Genomics: how to select the right approach to identify|
|16.05-16.30||The key role of proteomics in biomarker discovery||Harald|
|16.30-16.55||Novel approach for extracting information from|
experiments with multiple input factors
|17.15-17.30||Topological data analysis||Morten|
|17.30-17.50||Ultra-deep sequencing of mitochondrial DNA|
in single cells
|17.50-18.10||Integrated analysis of epigenomic and gene expression||Endre|
|19.30||Dinner - Enjoy a culinary experience at Solstrand Hotel|
& Bad with participants and presenters
MONDAY 19. June
|09.00-09.30||What are clinical trials?||Nina|
|09.30-09.50||Patient's view on clinical trials||Patient|
|Clinical trials for biomarker detection and evaluation |
- opportunities, benefits and challenges
|10.10-10.30||A clinician's view||Christian|
|10.30-10.50||A molecular biologist's view||Reidun|
|10.50-11.10||The biostatistician's view||Nello|
|11.10-11.30||The ethicist's view||Roger|
|Sample and data management|
|12.30-12.45||Biobank Haukeland, the research biobank at|
Haukeland University Hospital
|12.45-13.00||Pubgene for management and interpretation of genomic data||Randi|
|13.45-14.10||National services offered by Elixir Norway for non-sensitive and sensitive molecular Life Science data: NeLS and TSD||Kjell|
|Clinical mass cytometry|
|14.30-14.50||A practical example: A cross-sectional study for disease mechanisms in rheumatoid arthritis||Lucius|
|14.50-15.10||Antibody monitoring in multiple sclerosis||Gerd|
|15.10-15.30||An analytical approach: Are there any biomarker relevant molecular changes out there?||Jørn|
|15.30-15.45||Centre for Digital Life Norway - Opportunities for multidisciplinary research and innovation||Rune|
|15.45-15.55||Closing remarks||Ellen Mostleth and Sonia Gavasso|
See attachment below for printer friendly program.